[go: up one dir, main page]

FI91526B - Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi

Info

Publication number
FI91526B
FI91526B FI880282A FI880282A FI91526B FI 91526 B FI91526 B FI 91526B FI 880282 A FI880282 A FI 880282A FI 880282 A FI880282 A FI 880282A FI 91526 B FI91526 B FI 91526B
Authority
FI
Finland
Prior art keywords
triazoles
alkylsulfinyl
sulfonyl
aryl
preparation
Prior art date
Application number
FI880282A
Other languages
English (en)
Swedish (sv)
Other versions
FI880282L (fi
FI91526C (fi
FI880282A0 (fi
Inventor
John M Kane
Francis P Miller
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI880282A0 publication Critical patent/FI880282A0/fi
Publication of FI880282L publication Critical patent/FI880282L/fi
Application granted granted Critical
Publication of FI91526B publication Critical patent/FI91526B/fi
Publication of FI91526C publication Critical patent/FI91526C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI880282A 1987-01-27 1988-01-22 Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi FI91526C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US706387A 1987-01-27 1987-01-27
US12619187 1987-12-04
US07/126,191 US4900743A (en) 1987-01-27 1987-12-04 3-aryl-5-alkylthio-4H-1,2,4-triazoles
US706387 1996-08-30

Publications (4)

Publication Number Publication Date
FI880282A0 FI880282A0 (fi) 1988-01-22
FI880282L FI880282L (fi) 1988-07-28
FI91526B true FI91526B (fi) 1994-03-31
FI91526C FI91526C (fi) 1994-07-11

Family

ID=26676435

Family Applications (1)

Application Number Title Priority Date Filing Date
FI880282A FI91526C (fi) 1987-01-27 1988-01-22 Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi

Country Status (19)

Country Link
US (1) US4900743A (fi)
EP (1) EP0276793B1 (fi)
JP (1) JP2537651B2 (fi)
KR (1) KR960007166B1 (fi)
CN (1) CN1023480C (fi)
AR (1) AR244682A1 (fi)
AU (1) AU601013B2 (fi)
CA (1) CA1312605C (fi)
DE (1) DE3881712T2 (fi)
DK (1) DK171599B1 (fi)
ES (1) ES2058144T3 (fi)
FI (1) FI91526C (fi)
HU (1) HU205747B (fi)
IE (1) IE61188B1 (fi)
IL (1) IL85185A (fi)
NO (1) NO166642C (fi)
NZ (1) NZ223260A (fi)
PH (1) PH24513A (fi)
PT (1) PT86623B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006125A1 (en) * 1987-12-31 1989-07-13 Smithkline Beckman Corporation 4-aralkyl-5-substituted-1,2,4-triazole-5-thiols
AU644500B2 (en) * 1990-12-20 1993-12-09 Merrell Dow Pharmaceuticals Inc. 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma
DE4339412A1 (de) * 1993-11-18 1995-05-24 Bayer Ag Verfahren und neue Zwischenprodukte zur Herstellung von Triazolinonen
AR032653A1 (es) 2001-02-09 2003-11-19 Telik Inc Inhibidores heterociclicos del trasportador de glicina 2 composiciones farmaceuticas, uso y metodos.
CN1736381B (zh) * 2005-08-11 2010-09-08 沈阳药科大学 吗啉甲基萘满酮用于制备平滑肌解痉剂的用途
CN102245592A (zh) * 2008-12-12 2011-11-16 阿斯利康(瑞典)有限公司 制备4-[4-甲基-5-(c1-10 烷基硫基/c5-10芳基-c1-6 烷基硫基)-4h-1,2,4-三唑-3-基]吡啶的新方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU193891B (en) * 1984-02-07 1987-12-28 Gyogyszerkutato Intezet Process for production of new derivatives of 1,2,4-triasole

Also Published As

Publication number Publication date
AU601013B2 (en) 1990-08-30
FI880282L (fi) 1988-07-28
DE3881712D1 (de) 1993-07-22
US4900743A (en) 1990-02-13
EP0276793A2 (en) 1988-08-03
ES2058144T3 (es) 1994-11-01
HUT47257A (en) 1989-02-28
DE3881712T2 (de) 1993-12-23
PT86623A (pt) 1988-02-01
PT86623B (pt) 1993-01-29
FI91526C (fi) 1994-07-11
IL85185A0 (en) 1988-07-31
FI880282A0 (fi) 1988-01-22
EP0276793A3 (en) 1988-09-21
EP0276793B1 (en) 1993-06-16
NO166642B (no) 1991-05-13
AU1072888A (en) 1988-07-28
NO880337D0 (no) 1988-01-26
NO166642C (no) 1991-08-21
CN88100346A (zh) 1988-11-02
AR244682A1 (es) 1993-11-30
CN1023480C (zh) 1994-01-12
DK35488A (da) 1988-07-28
KR880008999A (ko) 1988-09-13
DK171599B1 (da) 1997-02-17
HU205747B (en) 1992-06-29
IL85185A (en) 1996-03-31
KR960007166B1 (ko) 1996-05-29
PH24513A (en) 1990-07-18
JPS63201176A (ja) 1988-08-19
NZ223260A (en) 1991-07-26
JP2537651B2 (ja) 1996-09-25
DK35488D0 (da) 1988-01-26
IE61188B1 (en) 1994-10-19
NO880337L (no) 1988-07-28
CA1312605C (en) 1993-01-12

Similar Documents

Publication Publication Date Title
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI874787A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten nor-statiini- ja nor-syklostatiinipolypeptidien valmistamiseksi
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
FI883064A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI90769C (fi) Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi
FI884497A0 (fi) Menetelmä uusien, aromataasia inhiboivien 4(5)-imidatsolien valmistamiseksi
FI875235A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia tetrahydro(imidatsolyylimetyyli)-4H-karbatsol-4-oneja
FI883632A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten eetterien valmistamiseksi
FI874459A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten piperidiinijohdannaisten valmistamiseksi
FI94752C (fi) Menetelmä terapeuttisesti käyttökelpoisten propenonioksiimieettereiden valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI880467A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI871087A0 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
FI93444B (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
FI881892A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 1,2,5,6-tetrahydropyridiinijohdannaisten valmistamiseksi
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI893003A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI93119B (fi) Uusien tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
FI92205C (fi) Menetelmä terapeuttisesti käyttökelpoisten N-pyrrolo- ja pyrido /3,2,1,-j k/ /1,4/ bentsodiatsepinyyli-N'-aryyliurea ja tioureajohdannaisten valmistamiseksi
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
FI892946A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi
FI880190A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia tetrahydrofuraanijohdoksia
FI884473A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.